Yoshimasa Kokado

Statistics

Publications

Citations

147

H-Index

Active since

2021

Affiliations

Mitsubishi Tanabe Pharma Corporation(Current)

Gunma University

The University of Tokyo

Yoshimasa Kokado is an author at Mitsubishi Tanabe Pharma Corporation specializing in pharmacology, medicine, and erythropoiesis-stimulating agent use.

ORCID

Publications per year

2021–2021

Publications

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD

Masaomi Nangaku, Kazuoki Kondo, Yoshimasa Kokado et al. · Journal of the American Society of Nephrology · 2021 · 75 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study

Masaomi Nangaku, Kazuoki Kondo, Kiichiro Ueta et al. · Nephrology Dialysis Transplantation · 2021 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

In Vitro and Clinical Pharmacokinetic Studies of the Effects of Iron-containing Agents on Vadadustat, an Oral Hypoxia-inducible Factor–Prolyl Hydroxylase Inhibitor

Yoshimasa Kokado, Kouji Kawai, Takehiro Nanjo et al. · Clinical Therapeutics · 2021 · 10 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–3 of 3